Corbus Pharmaceuticals I...

4.93
-0.27 (-5.19%)
At close: Apr 03, 2025, 3:59 PM
5.05
2.39%
After-hours: Apr 03, 2025, 07:56 PM EDT

Corbus Pharmaceuticals Statistics

Share Statistics

Corbus Pharmaceuticals has 12.23M shares outstanding. The number of shares has increased by 14.46% in one year.

Shares Outstanding 12.23M
Shares Change (YoY) 14.46%
Shares Change (QoQ) 0.43%
Owned by Institutions (%) 0%
Shares Floating 10.55M
Failed to Deliver (FTD) Shares 1.29K
FTD / Avg. Volume 0.54%

Short Selling Information

The latest short interest is 2.4M, so 19.68% of the outstanding shares have been sold short.

Short Interest 2.4M
Short % of Shares Out 19.68%
Short % of Float 22.01%
Short Ratio (days to cover) 8.99

Valuation Ratios

The PE ratio is -3.2 and the forward PE ratio is -1.73. Corbus Pharmaceuticals's PEG ratio is 0.05.

PE Ratio -3.2
Forward PE -1.73
PS Ratio 0
Forward PS 0.4
PB Ratio 0.9
P/FCF Ratio -3.08
PEG Ratio 0.05
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Corbus Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.94, with a Debt / Equity ratio of 0.02.

Current Ratio 12.94
Quick Ratio 12.94
Debt / Equity 0.02
Debt / EBITDA -
Debt / FCF -0.08
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.44M
Employee Count 28
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -86.49% in the last 52 weeks. The beta is 2.63, so Corbus Pharmaceuticals's price volatility has been higher than the market average.

Beta 2.63
52-Week Price Change -86.49%
50-Day Moving Average 7.86
200-Day Moving Average 26.66
Relative Strength Index (RSI) 28.93
Average Volume (20 Days) 239.73K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -40.21M
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -3.68
Full Income Statement

Balance Sheet

The company has 17.2M in cash and 3.24M in debt, giving a net cash position of 13.96M.

Cash & Cash Equivalents 17.2M
Total Debt 3.24M
Net Cash 13.96M
Retained Earnings -476.89M
Total Assets 155.88M
Working Capital 141.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -41.79M and capital expenditures 0, giving a free cash flow of -41.79M.

Operating Cash Flow -41.79M
Capital Expenditures 0
Free Cash Flow -41.79M
FCF Per Share -3.83
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRBP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CRBP is $52, which is 900% higher than the current price. The consensus rating is "Buy".

Price Target $52
Price Target Difference 900%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Stock Splits

The last stock split was on Feb 14, 2023. It was a backward split with a ratio of 1:30.

Last Split Date Feb 14, 2023
Split Type backward
Split Ratio 1:30

Scores

Altman Z-Score -1.34
Piotroski F-Score 1